|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia,Myeloid, Chronic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |||||
| Leukemia, Myeloid | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Hematologic Diseases | |||||
| Myeloproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| Heat Shock Protein 70 HSP70 | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Connecticut | |||||